These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2263671)
41. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors. Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136 [TBL] [Abstract][Full Text] [Related]
42. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Takao K; Nagatani T; Kitamura Y; Yamawaki S Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024 [TBL] [Abstract][Full Text] [Related]
43. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490 [TBL] [Abstract][Full Text] [Related]
44. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI. Lawton CL; Blundell JE Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689 [TBL] [Abstract][Full Text] [Related]
50. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices. Yamazaki J; Fukuda H; Nagao T; Ono H Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651 [TBL] [Abstract][Full Text] [Related]
51. Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Gewirtz JC; Marek GJ Neuropsychopharmacology; 2000 Nov; 23(5):569-76. PubMed ID: 11027922 [TBL] [Abstract][Full Text] [Related]
52. Functional interaction between 5-HT1B and 5-HT1A or 5-HT2 receptors in mice. Chojnacka-Wójcik E Pol J Pharmacol Pharm; 1992; 44(3):251-60. PubMed ID: 1470563 [TBL] [Abstract][Full Text] [Related]
53. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
54. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Maura G; Roccatagliata E; Ulivi M; Raiteri M Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025 [TBL] [Abstract][Full Text] [Related]
55. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714 [TBL] [Abstract][Full Text] [Related]
56. Different functions of spinal 5-HT1A and 5-HT2 receptor subtypes in modulating behaviour induced by excitatory amino acid receptor agonists in mice. Mjellem N; Lund A; Hole K Brain Res; 1993 Oct; 626(1-2):78-82. PubMed ID: 7506633 [TBL] [Abstract][Full Text] [Related]
57. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Arnt J; Hyttel J Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390 [TBL] [Abstract][Full Text] [Related]
58. Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats. Freo U; Soncrant TT; Holloway HW; Rapoport SI Brain Res; 1991 Feb; 541(1):63-9. PubMed ID: 2029625 [TBL] [Abstract][Full Text] [Related]
59. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Shannon M; Battaglia G; Glennon RA; Titeler M Eur J Pharmacol; 1984 Jun; 102(1):23-9. PubMed ID: 6479216 [TBL] [Abstract][Full Text] [Related]